793 Five day oral etoposide treatment for advanced small cell lung cancer (SCLC): Quality of life (QOL) assessment in a randomised comparison with intravenous chemotherapy

✍ Scribed by Harper, P.G.; James, L.E.; Spiro, S.G.; Rudd, R.M.; Ruiz de Elvira, M.-C.; Gower, N.H.; Lamont, A.

• Book ID: 123572233
• Publisher: Elsevier Science
• Year: 1997
• Tongue: English
• Weight: 292 KB
• Volume: 18
• Category: Article
• ISSN: 0169-5002
• DOI: 10.1016/S0169-5002(97)80172-9